Heart Pump Accessory Removal: Abbott Removes HeartMate Mobile Power Unit due to Instances of Sudden Power Loss
Heart Pump Accessory Removal: Abbott Removes HeartMate Mobile Power Unit due to Instances of Sudden Power Loss
Italiano
Heart Pump Accessory Removal: Abbott Removes HeartMate Mobile Power Unit due to Instances of Sudden Power Loss
FDA is alerting health care providers and lab staff of reports of false positives when using certain Micro Capillary Blood Collection tubes with the LeadCare Testing Systems.
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program
Bridgewater, NJ, Amneal Pharmaceutical LLC, is recalling two lots of Ropivacaine Hydrochloride Injection, USP, 500mg/100mL, Infusion bags to the hospital/user level as the products may contain an inert fiber identified as polypropylene fibers from the IV bag.
On April 7, 2025, the U.S. Food and Drug Administration (“FDA” or “the agency”), classified Q’Apel Medical, Inc.’s (“Q’Apel” or “the company”) voluntary recall of 1,617 units of its 072 Aspiration System (also known under the product name “Hippo”, which includes “Cheetah”; collectively, the “product
Un déficit biallélique confirmé génétiquement en pro-opiomélanocortine (POMC), en proprotéine convertase subtilisine/kexine de type 1 (PCSK1) ou en récepteur de la leptine (LEPR) dû à des variants interprétés comme étant pathogènes, probablement pathogènes ou de signification indéterminée.
Pour réduire le risque de déclin soutenu du DFGe, de néphropathie terminale et de décès d’origine cardiovasculaire et rénale chez les adultes atteints de maladie rénale chronique.
80.211.154.110